OAKDALE, Mar. 11th, 2021 -- Salspera, LLC, a clinical-stage biopharmaceutical company dedicated to the development of microbial based immunotherapies for cancer, today announced that it will present a poster at the American Association for Cancer Research (AACR) Annual Meeting, to be held in a virtual format from April 10th to 15th and May 17th to 21st, 2021.
Title: Microbial based immunotherapy: Saltikva as a novel therapeutic for solid tumors
Session Title: Immunomodulatory Agents and Interventions
Session Category: Immunology
Abstract Number: 5052, e-poster
Date and Time: Saturday, April 10, 2021, 8:30 a.m. ET via the AACR website, www.aacr.org
Keywords: Saltikva, cancer, oncology, immune, therapy, immunotherapy, bacterial based cancer therapy, microbial immunotherapy, chemotherapy, pancreatic cancer, tumor microenvironment, immuno oncology, interleukin-2, cytokine, bacteria, Salspera